Clinical trial

Postpartum Hypertension Study

NCT05139238

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2022-07-04

PhasePHASE4

Study timeline

Study start (actual)2022-07-04Date precision: day

Registry last updated2026-05-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Postpartum Pregnancy-Induced Hypertensionunresolved

Postpartum Preeclampsiaunresolved

Pregnancy-Induced Hypertension in Postpartumunresolved

Hypertensive Emergencyverified · MONDO: malignant hypertension

Interventions

LabetalolDRUG · verified · RxNorm: labetalol

NifedipineDRUG · verified · RxNorm: nifedipine

Sponsors & collaborators

Columbia Universitylead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05139238 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.